NAMS smart money

Newamsterdam Pharma Co N.V. (NAMS): 1 insider buy, 10 top funds holding it, 1 ETF change in the public filings.

Insider buys, 12 months$226k

Insider buys

FiledWhoRoleAmountPrice
2026-09-15Davidson Michael H.Chief Executive Officer$226k$22.65

Top 100 funds holding it

#FundChangeWeightValue
29Slate Path Capital LP0.12%$8M
31Affinity Asset Advisors, LLC0.39%$7M
31Affinity Asset Advisors, LLC0.18%$3M
48Nwi Management LP0.96%$17M
58Bain Capital Life Sciences Investors, LLC6.21%$93M
58Bain Capital Life Sciences Investors, LLC0.08%$1M
67Duquesne Family Office LLCADD +9%1.97%$82M
74First Turn Management, LLCADD +21%2.27%$17M
76Polar Capital Holdings PLCTRIM -50%0.06%$21M
86Adar1 Capital Management, LLC0.13%$3M

ETF changes

ETFChangeValueReport
Capital Group U.S. Small And Mid Cap ETFADD+$19M2026-05-31
Open the live smart money map